… challenge to the successful treatment of oral candidiasis.6 Azoles are widely … and behavioral factors in the development of these infections.1,17 … rates to commonly used antifungal drugs, especially fluconazole, particularly in areas …

… including histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and … who develops a new infection during treatment with … biologic disease-modifying antirheumatic drugs (DMARDs) (e. … reported during clinical trials for patients treated …

… of Brexafemme in invasive candidiasis, the company said in … indications of vulvovaginal candidiasis (VVC) and refractory vulvovaginal candidiasis (rVVC), … . When the FDA lifted a clinical trial hold after 19 … new class of antifungal drugs to the indication. GSK …

… ongoing, global Phase III ReSPECT trial evaluating REZZAYO® (rezafungin). … controlled, pivotal Phase 3 trial of rezafungin versus the … Dr Yuri Martina, Chief Development and Medical Officer at … is indicated for the treatment of invasive candidiasis in adults.5 …

… specified statistical strategies. Using the treatment policy strategy, HiSCR75 response … safety profile, consistent with earlier trials. Treatment-emergent adverse events (TEAEs) occurred … respiratory tract infections. Oral candidiasis occurred in 7.3% of …

… and zero cases of candidiasis reported across all patients, … and transform existing FDA-approved drugs to improve their … where Eupraxia currently is developing advanced treatments, to also be … #47;2 trial, the RESOLVE trial, for the treatment of EoE. …

… toward our goal of seeking FDA approval for REZZAYO in the … options for the treatment of candidemia and invasive candidiasis. Approval of this … in clinical trial patients treated with REZZAYO. Monitor patients who develop abnormal …

… 3 trials, marking a potential shift in treatment options … common adverse event was candidiasis (13.7%), occurring … centrifugal cicatricial alopecia, ritlecitinib treatment led to significant improvements … FDA approval in July 2025 as the first treatment …

… processes often rely on trial-and-error screening, which … diversifying and improving antifungal drugs to bypass resistance. … industry to develop these findings into antifungal treatments. As a … It can cause systemic candidiasis, a severe invasive infection …

… Technology (IIT) Madras, developed a multidisciplinary approach to … diversifying and improving antifungal drugs to bypass resistance. … reduce mortality, and lower treatment costs,” added Prof. … individuals. It causes ‘Systemic candidiasis’, a severe, invasive …